C-type lectins |
|
|
|
Asialoglycoprotein receptor (ASGR) |
Mainly hepatocytes |
Desialylated glycoproteins that containterminal Gal or GalNAc residues on theirN-linked glycans, and also sialylatedglycoproteins with terminal Siaα2,6GalNAcand Siaα2,6Gal |
Reviewed in [265, 266] |
CD209/DC-SIGN |
Human myeloid dendritic cells |
Branched D-Man and L-Fuc motifscommon on pathogen surfaces; e.g.,mannan, Lex and Ley |
Reviewed in [267] |
Langerin (CD207) |
Mainly Langerhans cells |
Man-rich N-glycans on proteins;e.g., HIV-1 gp120 envelope protein |
[268] |
Man-binding lectin |
Mainly hepatocytes |
Man-rich N-glycans |
[269] |
(MBL2) |
|
|
|
I-type lectins (they bind to non-reducing terminal sialic acids) |
|
|
|
Sialic acid binding Ig like lectin 1 (SIGLEC1/CD169) |
Macrophages |
e.g., HIV-1 gp120 envelope protein |
[270] |
CD22 |
B cells |
Sialoside ligands on the surface of both the same cell and adjacent cells |
[271] |
Galectins (they bind to β-galactoside-containing glycans) |
|
|
|
LGALS1 |
e.g. T cells |
e.g., PTPRC/CD45 |
[272] |
LGALS3 |
e.g. fibroblasts |
e.g., CD44 or glycosphingolipids |
[148] |
Plant lectins/toxins |
|
|
|
Ricin (R-type lectin) |
Ricinus communis |
Terminal β-linked Gal- or GalNAc-containing glycans |
Reviewed in [273] |
Gs I-A4 |
Griffonia (Bandeirea) simplicifolia
|
Terminal α‐linked GalNAc residues, including the Tn antigen |
[274] |
Bacterial lectins/toxins |
|
|
|
StxB |
Shigella dysenteriae and Escherichia coli
|
Mainly Gb3 |
[136] |
Cholera toxin |
Vibrio cholerae |
Ganglioside GM1, LeX on proteins |
[275] |
LecA |
Pseudomonas aeruginosa |
e.g., Gb3 |
[142] |
RSL |
Ralstonia solanacearum |
e.g., human histo-blood group antigens |
[132] |
Viral lectins |
|
|
|
VP1 |
Simian virus 40 |
Ganglioside GM1 |
[140] |
VP1 |
Norovirus GII.4 |
ABH histo-blood group glycans on glycoproteins and GSLs |
[141] |